Fig. 2. In vivo antitumor effect after intra-tumoral treatment with PBS as control, TQ, and TQ-loaded LNCs at 5 mg kg−1 body weight and unloaded LNCs on a subcutaneous colorectal cancer model (n = 6 mice/group). (A) Macroscopic effects on mouse tumor at day 15. (B) Progression of mean tumor volume measured using a caliper. (C) Tumor inhibitory rate (***: P < 0.01).
